Veterans’ RightsAn independent resource for veterans
← All decisions
Remanded (sent back)

The Veteran's GERD is being remanded for a VA medical opinion to determine if it is related to the Isoniazid medication taken to treat his TB exposure during service in Operation Iraqi Freedom.

The deciding factor: A VA medical opinion is needed to assess whether the GERD is related to the Isoniazid used to treat the Veteran's TB exposure while deployed in Iraq.

Claimed conditions
acid reflux/gastroesophageal reflux disease (GERD), tuberculosis (TB)
How they argued it
Secondary to another service-connected condition
Exposure basis
Gulf War
Rating assigned
None in this decision
Decision date
January 30, 2026
Citation
A26009064

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A26009064.

What this means for you

A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.